Effect of oral zinc regimens on human hepatic copper content: a randomized intervention study
Abstract Zinc inhibits intestinal copper uptake, an effect utilized for treating Wilson’s disease (WD). We used copper-64 (64Cu) PET/CT to examine how much four weeks of treatment with different zinc regimens reduced the hepatic 64Cu content after oral 64Cu administration and test if alternative reg...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2022-08-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-022-18872-8 |
| _version_ | 1798004420803297280 |
|---|---|
| author | Ditte Emilie Munk Tea Lund Laursen Frederik Teicher Kirk Hendrik Vilstrup Aftab Ala Lars Christian Gormsen Peter Ott Thomas Damgaard Sandahl |
| author_facet | Ditte Emilie Munk Tea Lund Laursen Frederik Teicher Kirk Hendrik Vilstrup Aftab Ala Lars Christian Gormsen Peter Ott Thomas Damgaard Sandahl |
| author_sort | Ditte Emilie Munk |
| collection | DOAJ |
| description | Abstract Zinc inhibits intestinal copper uptake, an effect utilized for treating Wilson’s disease (WD). We used copper-64 (64Cu) PET/CT to examine how much four weeks of treatment with different zinc regimens reduced the hepatic 64Cu content after oral 64Cu administration and test if alternative regimens were noninferior to the standard regimen of zinc acetate 50 mg × 3 daily. Forty healthy persons were randomized to four different zinc protocols. The WD standard treatment zinc acetate 50 mg × 3 reduced the hepatic 64Cu content from 26.9 ± 7.5% to 13.3 ± 5.6% of the administered 64Cu. Zinc gluconate 50 mg × 3 was noninferior (P = 0.02) (35.8 ± 9.0% to 17.4 ± 7.5%). Zinc acetate 150 mg × 1 (33.1 ± 9.9% to 17.4 ± 7.5%) and zinc gluconate 150 mg × 1 (28.1 ± 6.7% to 22.0 ± 6.7%) were less effective. These effects were intra- and inter-individually highly variable, and 14% had no effect of any zinc regimen, which may explain disparities in zinc treatment efficacy in WD patients. |
| first_indexed | 2024-04-11T12:23:24Z |
| format | Article |
| id | doaj.art-2e7e1fd3793649e4ac2dd3acc0061b69 |
| institution | Directory Open Access Journal |
| issn | 2045-2322 |
| language | English |
| last_indexed | 2024-04-11T12:23:24Z |
| publishDate | 2022-08-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj.art-2e7e1fd3793649e4ac2dd3acc0061b692022-12-22T04:24:01ZengNature PortfolioScientific Reports2045-23222022-08-0112111010.1038/s41598-022-18872-8Effect of oral zinc regimens on human hepatic copper content: a randomized intervention studyDitte Emilie Munk0Tea Lund Laursen1Frederik Teicher Kirk2Hendrik Vilstrup3Aftab Ala4Lars Christian Gormsen5Peter Ott6Thomas Damgaard Sandahl7Department of Hepatology and Gastroenterology, Aarhus University HospitalDepartment of Hepatology and Gastroenterology, Aarhus University HospitalDepartment of Hepatology and Gastroenterology, Aarhus University HospitalDepartment of Hepatology and Gastroenterology, Aarhus University HospitalInstitute of Liver Studies, King’s College Hospital NHS Foundation TrustDepartment of Nuclear Medicine and PET Centre, Aarhus University HospitalDepartment of Hepatology and Gastroenterology, Aarhus University HospitalDepartment of Hepatology and Gastroenterology, Aarhus University HospitalAbstract Zinc inhibits intestinal copper uptake, an effect utilized for treating Wilson’s disease (WD). We used copper-64 (64Cu) PET/CT to examine how much four weeks of treatment with different zinc regimens reduced the hepatic 64Cu content after oral 64Cu administration and test if alternative regimens were noninferior to the standard regimen of zinc acetate 50 mg × 3 daily. Forty healthy persons were randomized to four different zinc protocols. The WD standard treatment zinc acetate 50 mg × 3 reduced the hepatic 64Cu content from 26.9 ± 7.5% to 13.3 ± 5.6% of the administered 64Cu. Zinc gluconate 50 mg × 3 was noninferior (P = 0.02) (35.8 ± 9.0% to 17.4 ± 7.5%). Zinc acetate 150 mg × 1 (33.1 ± 9.9% to 17.4 ± 7.5%) and zinc gluconate 150 mg × 1 (28.1 ± 6.7% to 22.0 ± 6.7%) were less effective. These effects were intra- and inter-individually highly variable, and 14% had no effect of any zinc regimen, which may explain disparities in zinc treatment efficacy in WD patients.https://doi.org/10.1038/s41598-022-18872-8 |
| spellingShingle | Ditte Emilie Munk Tea Lund Laursen Frederik Teicher Kirk Hendrik Vilstrup Aftab Ala Lars Christian Gormsen Peter Ott Thomas Damgaard Sandahl Effect of oral zinc regimens on human hepatic copper content: a randomized intervention study Scientific Reports |
| title | Effect of oral zinc regimens on human hepatic copper content: a randomized intervention study |
| title_full | Effect of oral zinc regimens on human hepatic copper content: a randomized intervention study |
| title_fullStr | Effect of oral zinc regimens on human hepatic copper content: a randomized intervention study |
| title_full_unstemmed | Effect of oral zinc regimens on human hepatic copper content: a randomized intervention study |
| title_short | Effect of oral zinc regimens on human hepatic copper content: a randomized intervention study |
| title_sort | effect of oral zinc regimens on human hepatic copper content a randomized intervention study |
| url | https://doi.org/10.1038/s41598-022-18872-8 |
| work_keys_str_mv | AT ditteemiliemunk effectoforalzincregimensonhumanhepaticcoppercontentarandomizedinterventionstudy AT tealundlaursen effectoforalzincregimensonhumanhepaticcoppercontentarandomizedinterventionstudy AT frederikteicherkirk effectoforalzincregimensonhumanhepaticcoppercontentarandomizedinterventionstudy AT hendrikvilstrup effectoforalzincregimensonhumanhepaticcoppercontentarandomizedinterventionstudy AT aftabala effectoforalzincregimensonhumanhepaticcoppercontentarandomizedinterventionstudy AT larschristiangormsen effectoforalzincregimensonhumanhepaticcoppercontentarandomizedinterventionstudy AT peterott effectoforalzincregimensonhumanhepaticcoppercontentarandomizedinterventionstudy AT thomasdamgaardsandahl effectoforalzincregimensonhumanhepaticcoppercontentarandomizedinterventionstudy |